General
Anonymous Unlinked Surveys
Sexually Transmitted Disease Clinics
Drug Treatment Centers
Adolescent Medicine Clinics
Job Corps Entrants
Applicants for Military Service
Blood Donors

General

Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991;253:37-42.

CDC. HIV/AIDS Surveillance Report 1999, U.S. HIV and AIDS cases reported through June 2000, Midyear edition;12(No. 1):1-42. Accessed May 16, 2001.

CDC. HIV/AIDS Surveillance Report 1999, U.S. HIV and AIDS cases reported through December 1999, Year-end edition;11(No. 2):1-44. Accessed May 16, 2001.

CDC. National HIV Prevalence Surveys: 1997 Summary. Atlanta: CDC; 1998:1-25. Accessed May 16, 2001.

CDC. Interpretation and use of the Western Blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989;38(No. S-7):1-7.

CDC. National HIV Serosurveillance Summary: Results through 1992. Atlanta: CDC; 1994:1-51. Accessed May 16, 2001.

CDC. National HIV Serosurveillance Summary: Update–1993. Atlanta: CDC; 1995:1-9. Accessed May 16, 2001. CDC.

CDC Guidelines for National Human Immunodeficiency Virus Case Surveillance, Including Monitoring for Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. MMWR 1999;48(RR-13):1-31.

Dondero TJ, Gill ON. Large-scale HIV serologic surveys: what has been learned? AIDS 1991;5(suppl 2):S63-9.

Dondero T, Pappaioanou M, Curran JW. Monitoring the levels and trends of HIV infection: the Public Health Service’s HIV Surveillance Program. Public Health Rep 1988;103:213-20.

Fleming PL, Wortley PM, Karon JM, DeCock KM. Tracking the HIV epidemic: current issues, future challenges. Am J Public Health 2000;90:1037-41.

Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes [published correction appears in JAMA 1999;281:1893]. JAMA 1998;280:422-48.

Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276:126-31.

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: Government Printing Office; 1988. Publication GPO 887-890.

Pappaioanou M, Dondero TJ, Petersen LR, Onorato IM, Sanchez CD, Curran JW. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Public Health Rep 1990;105:113-9.

Valdiserri RO, Janssen RS, Buehler JW, Fleming PL. The context of HIV/AIDS surveillance. J Acquir Immune Defic Syndr 2000;25:S97-S104.

Back to top

Anonymous Unlinked Surveys

Bayer R. The ethics of blinded HIV surveillance testing. Am J Public Health 1993;83:496-7.

CDC. Protocol 2319: Anonymous Unlinked Surveys for HIV Incidence and Prevalence. Atlanta: CDC; 1999:1-78.

Back to top

Sexually Transmitted Disease Clinics

McCray E, Onorato IM. Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. J Sex Transm Dis 1992;19:235-41.

Onorato IM, McCray E, Pappaioanou M, et al. HIV seroprevalence surveys in sexually transmitted disease clinics. Public Health Rep 1990:105:119-24.

Valleroy LA, MacKellar DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men. JAMA 2000;284:198-204.

Weinstock HS, Sweeney S, Satten GA, Gwinn M. HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:506-12.

Weinstock HS, Sidhu J, Gwinn M, Karon J, Petersen LR. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:514-22.

Back to top

Drug Treatment Centers

Allen DM, Onorato IM, Green TA. HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. Am J Public Health 1992;82:541-6.

Battjes RJ, Pickens RW, Brown LS. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update. J Acquir Immune Defic Syndr 1995;10:90-6.

Bordelon KA, Murrill CS, Royalty JE, Miller MS, Gwinn M. Self-reported sexual risk behaviors among injection drug users admitted to drug treatment. In: Abstracts for the 127th Annual Meeting and Exposition, American Public Health Association, Chicago; November 1999. [Abstract 1015].

Hoffman JP, Su SS, Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend 1997;46:41-51.

Jones TS, Allen DM, Onorato IM, Petersen LR, Dondero TJ, Pappaioanou M. HIV seroprevalence surveys in drug treatment centers. Public Health Rep 1990;105:125-30.

Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. JAIDS 2000;25:63-70.

Murrill CS, Tun W, Miller MS, Royalty JE, Linley LA, Gwinn M. Reduction in self-reported injection-related risk behaviors among injecting drug users admitted to drug treatment. In: Abstracts for the 126th Annual Meeting and Exposition, American Public Health Association, Washington, DC; November 1998. [Abstract 2102].

Murrill CS, Prevots DR, Miller MS, Linley LA, Royalty JE, Gwinn M. Incidence of HIV among injection drug users entering drug treatment programs in four U.S. cities. J Urban Health 2001;78:152-61.

Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:499-509.

Prevots DR, Allen DM, Lehman JS, Green TA, Petersen LR, Gwinn M. Trends in human immuno-deficiency virus seroprevalence among injecting drug users entering drug treatment centers, United States, 1988-93. Am J Epidemiol 1996,143:733-42.

Back to top

Adolescent Medicine Clinics

Lindegren ML, Hansen C, Miller K, Byers RH, Onorato IM. Epidemiology of human immunodeficiency virus infection in adolescents, United States. Pediatr Infect Dis J 1994;13:525-35.

Sweeney P, Lindegren ML, Buehler JW, Onorato IM, Janssen RS. Teenagers at risk of human immunodeficiency virus type 1 infection. Arch Pediatr Adolesc Med 1995;149:521-8.

Wendell DA, Onorato IM, McCray E, Allen DM, Sweeney PA. Youth at risk: sex, drugs, and human immunodeficiency virus. Am J Dis Child 1992;146:76-81.

Back to top

Job Corps Entrants

Conway GA, Epstein MR, Hayman CR, et al. Trends in HIV prevalence among disadvantaged youth: survey results from a national job training program, 1988 through 1992. JAMA 1993;269:2887-9.

St. Louis ME, Conway GA, Hayman CR, Miller C, Petersen LR, Dondero TJ. Human immunodeficiency virus infection in disadvantaged adolescents: findings from the US Job Corps. JAMA 1991;266:2387-91.

Valleroy LA, MacKellar DA, Karon JM, Janssen RS, Hayman CR. HIV infection in disadvantaged out-of-school youth: prevalence for U.S. Job Corps entrants, 1990 through 1996. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:67-73.

Back to top

Applicants for Military Service

Burke DS, Brundage JF, Goldenbaum M, et al. Human immunodeficiency virus infections in teenagers: seroprevalence among applicants for military service. JAMA 1990;263:2074-7.

Brundage JF, Burke DS, Gardner LI, et al. Tracking the spread of the HIV infection epidemic among young adults in the US: results of the first four years of screening among civilian applicants for military service. J Acquir Immune Defic Syndr 1990;3:1168-80.

Back to top

Blood Donors

Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. JAMA 2000;284:229-35.

Back to top